Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-04-24 | New | $16,499,982 | $16,499,982 | Equity Only | 06b | SEC link |
| 2023-11-08 | New | $0 | $0 | Equity Only | 06b | SEC link |
| 2022-12-23 | New | $79,749,950 | $79,749,950 | Equity Only | 06b | SEC link |
| 2022-11-01 | Amended | $62,499,913 | $24,999,918 | Equity Only | 06b | SEC link |
| 2022-05-10 | New | $37,499,995 | $37,499,995 | Equity Only | 06b | SEC link |
| 2020-04-07 | New | $15,000,000 | $15,000,000 | Equity Only | 06b | SEC link |
| 2019-08-07 | Amended | $25,575,714 | $6,000,000 | Equity Only | 06b | SEC link |
| 2019-01-10 | Amended | $19,575,714 | $10,000,000 | Equity Only | 06b | SEC link |
| 2018-08-09 | Amended | $9,575,714 | $4,500,001 | Equity Only | 06b | SEC link |
| 2018-07-06 | New | $5,075,713 | $5,075,713 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Joseph C. Avellone | Director |
| Francois Beaubien | Director |
| Gerald Chan | Director |
| Isaac Cheng | Director |
| Chris C. Dimitropoulos | Director |
| Ron Farquhar | Director |
| Paul Fonteyne | Director |
| James Galeota | Director |
| Rosy Hu | Director |
| Ruoxi Hu | Director |
| Stefan Larson | Director |
| Kevin C. Lind | Director |
| Lawrence G. Miller | Director, Executive |
| Dennis Molnar | Executive |
| Michael Rogers | Executive |
| Gary Sender | Director |
| Barry Wohl | Executive |